Expression and characterization of Kunitz domain 3 and C-terminal of human tissue factor pathway inhibitor-2

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 11, 2009, Pages 948-954

  Zhu, Lina ^a   Wang, Jiping ^a   Mu, Jingui ^a   Wang, Huijun ^a   Zhang, Chenqi ^a   Wang, Jue ^a   Liu, Xingang ^a   Yan, Xiaomin ^a   Dai, Linsen ^a   Ma, Duan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Heparin; Kunitz domain 3 and C terminal of hTFPI 2; Pichia pastoris; Secondary structure

Indexed keywords

GLYCOPROTEIN; HEPARIN; PLACENTA PROTEIN 5; RECOMBINANT PROTEIN; TISSUE-FACTOR-PATHWAY INHIBITOR 2;

ARTICLE; CHEMISTRY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PICHIA; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN TERTIARY STRUCTURE;

GLYCOPROTEINS; HEPARIN; HUMANS; PICHIA; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS;

PICHIA PASTORIS;

EID: 70449627500     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp089     Document Type: Article

References (30)

1. Petersen LC, Sprecher CA, Foster DC, Blumberg H, Hamamoto T and Kisiel W. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 1996, 35: 266-272.
2. Kong D, Ma D, Bai H, Guo H, Cai X, Mo W and Tang Q, et al. Expression and characterization of the first Kunitz domain of human tissue factor pathway inhibitor-2. Biochem Biophys Res Commun 2004, 324: 1179-1185.
3. Du X, Chand HS and Kisiel W. Human tissue factor pathway inhibitor-2 does not bind or inhibit activated matrix metalloproteinase-1. Biochim Biophys Acta 2003, 1621: 242-245.
4. Rao CN, Gomez DE, Woodley DT and Thorgeirsson UP. Partial characterization of novel serine proteinase inhibitors from human umbilical vein endothelial cells. Arch Biochem Biophys 1995, 319: 55-62.
5. Rao CN, Reddy P, Liu Y, Toole EO, Reeder D, Foster DC and Kisiel W, et al. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Arch Biochem Biophys 1996, 335: 82-92.
6. Rao CN, Peavey CL, Liu YY, Lapiere JC and Woodley DT. Partial characterization of matrix-associated serine protease inhibitors from human skin cells. J Invest Dermatol 1995, 104: 379-383.
7. Yueying L, Sharon MS, Sanjani SL, Azim JK, David TW, Jasti SR and Rao CN. Matrix localization of tissue factor pathway inhibitor-2/matrixassociated serine protease inhibitor (TFPI-2/MSPI) involves arginine- mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin. Arch Biochem Biophys 1999, 370: 112-118.
8. Sprecher CA, Kisiel W, Mathewes S and Foster DC. Molecular cloning, expression, and partial characterization of a second human tissue factor pathway inhibitor. Proc Natl Acad Sci USA 1994, 91: 3353-3357. (Pubitemid 24130235)
9. Miyagi Y, Koshikawa N, Yasumitsu H, Miyagi E, Hirahara F, Aoki I and Misugi K. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2. J Biochem 1994, 116: 939-942.
10. Burgering MJ and Orbons LP. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa. J Mol Biol 1997, 269: 395-407.
11. Mine S and Yamazaki T. Structural mechanism for heparin-binding of the third Kunitz domain of human tissue factor pathway inhibitor. Biochemistry 2002, 41: 78-85.
12. Zhang E, St Charles R and Tulinsky A. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. J Mol Biol 1999, 285: 2089-2104.
13. Kamei S, Petersen LC, Sprecher CA, Foster DC and Kisiel W. Inhibitory properties of human recombinant Arg24 Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2). Thromb Res 1999, 94: 147-152.
14. Chand HS, Schmidt AE, Bajaj SP and Kisiel W. Structure function analysis of the reactive site in the first kunitz-type domain of human tissue factor pathway inhibitor-2. J Biol Chem 2004, 279: 17500-17507.
15. Hiroyuki K, Kaori I, Guohui F, Setsuko A, Sannamu L, Gohsuke S and Naotaka H. Secondary structures of synthetic peptides corresponding to the first membrane-contact portion of normal band 3 and its deletion mutant (Southeast Asian Ovalocytosis). J Biochem 1998, 124: 509-518.
16. Zhang C, Kong D, Liu X, Yan X, Dai L and Ma D. Spectroscopic analysis on the effect of temperature on Kunitz domain 1 of human tissue factor pathway inhibitor-2. Acta Biochim Biophys Sin 2007, 39: 406-412.
17. Nevskaya NA and Chirgadze YN. Infrared-spectra and resonance interactions of amide-I and amide-II vibrations of alpha-helix. Biopolymers 1976, 15: 637-648.
18. Narasimha S, Venyaminov SY and Robert WW. Estimation of the number of α-helical and β-strand segments in proteins using circular dichroism spectroscopy. Protein Sci 1999, 8: 370-380.
19. Cereghino JL and Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 2000, 24: 45-66.
20. Clare JJ, Rayment FB, Ballantine SP, Sreekrishna K and Romanos MA. High-level expression of tetanus toxin fragment c in Pichia pastoris strains containing multiple tandem integrations of the gene. Biotechnology 1991, 9: 455-460.
21. Carolina PI and Miguel AN. K2D2: estimate of protein secondary structure from circular dichroism spectra. BMC Struct Biol 2007, 8: 25.
22. Andrade MA, Chacon P, Merelo JJ and Moran F. Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network. Protein Eng 1993, 6: 383-390.
23. Tim JK, Sangeeta BJ, Donald M, Lori P, Karen T, Damon P and Meili L, et al. Parathyroid hormone is a heparin/polyanion binding protein: binding energetics and structure modification. Protein Sci 2007, 16: 1193-1203.
24. Barbier GG, Joshi RC, Campbell ER and Campbell WH. Purification and biochemical characterization of simplified eukaryotic nitrate reductase expressed in Pichia pastoris. Protein Expr Purif 2004, 37: 61-71.
25. Heng-Yen P, Whittaker MM, Romaric B, Anne B, Bernier F and James WW. Characterization of wheat germin (oxalate oxidase) expressed by Pichia pastoris. Biochem Biophys Res Commun 2007, 356: 925-929.
26. Romanos MA, Clare JJ, Beesley KM, Rayment FB, Ballantine SP, Makoff AJ and Dougan G, et al. Recombinant Bordetella pertussis peractin (P69) from the yeast Pichia pastoris: high-level production and immunological properties. Vaccine 1991, 9: 901-906.
27. Zhu H, Shi J, Cregg JM and Woldegiogis G. Reconstitution of highly expressed human heart muscle carnitine palmitoyltransferase I. Biochem Biophys Res Commun 1987, 239: 498-502.
28. Yuan CH and Song PL. Research on the structure-function relationship of Kunitz-type serine protease inhibitor. Life Sci Res 2003, 7: 110-115.
29. Griffith MJ. Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. J Biol Chem 1982, 257: 7360-7365.
30. Pratt CW, Whinna HC and Church FC. A comparison of three heparinbinding serine proteinase inhibitors. J Biol Chem 1992, 267: 8795-8801.